MedTrace Logo

Post-op Crowd Sourcing Health Data Via Text-messaging

NCT03532256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2025-06-04

Study results available
· View outcomes & findings →

Summary

The Center for Disease Control has labeled the opioid prescription drug crisis an "epidemic" in the United States and recently this epidemic has been named a public health emergency. Various medical and surgical societies have begun to release general opioid prescribing guidelines for providers addressing acute pain, but these do not highlight the patient perspective or experience. Identifying an acceptable opioid dose and duration has remained a challenge and is a nuanced process. Though policy and provider driven changes may begin to augment practice, these avenues may miss a crucial perspective; the patient's.

Conditions

  • Orthopedic Surgery
  • Opioid Use
  • Acute Injuries Knee
  • Neurosurgery
  • Surgery

Interventions

BEHAVIORAL

Observation

Patients will be contacted postoperatively via an automated text-message to assess pain, functional status, and opioid consumption.

BEHAVIORAL

Text to online survey

Subset of surgical patients will receive an automated text message with a link to a secure online survey with questions that assess pain, functional status, and opioid consumption.

BEHAVIORAL

Bi-directional text script

Subset of surgical patients will receive an automated bi-directional text message script with questions that assess pain, functional status, and opioid consumption.

Sponsors & Collaborators

Principal Investigators

  • M. Kit Delgado, MD, MS · University of Pennsylvania

  • Zarina Ali, MD · University of Pennsylvania

  • Anish Agarwal, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2019-09-16
Completion
2019-09-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03532256 on ClinicalTrials.gov